Terkko Navigator / Molecular Psychiatry

Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany

Functional brain rewiring and altered cortical stability in ulcerative colitis

CB1 receptor activation rapidly alters synaptic vesicle numbers in mouse hippocampal synapses

The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis

Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats

Alterations in brain synaptic proteins and mRNAs in mood disorders: a systematic review and meta-analysis of postmortem brain studies

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach

Inhibition of Trpv4 rescues circuit and social deficits unmasked by acute inflammatory response in a Shank3 mouse model of Autism

Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice via the immediate early gene Egr3

Unconsidered issues of measurement noninvariance in biological psychiatry: A focus on biological phenotypes of psychopathology

Gastrin-releasing peptide regulates fear learning under stressed conditions via activation of the amygdalostriatal transition area

Application of deep learning algorithm on whole genome sequencing data uncovers structural variants associated with multiple mental disorders in African American patients

Genetic heterogeneity and subtypes of major depression

Hippocampal acetylcholine modulates stress-related behaviors independent of specific cholinergic inputs

Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis

Comment to: Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy?

Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis

Epigenome-wide meta-analysis of PTSD symptom severity in three military cohorts implicates DNA methylation changes in genes involved in immune system and oxidative stress

Maternal mid-gestational and child cord blood immune signatures are strongly associated with offspring risk of ASD

A novel peripheral biomarker for depression and antidepressant response

Novel open reading frames in human accelerated regions and transposable elements reveal new leads to understand schizophrenia and bipolar disorder

A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism

Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms

Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine

Pyroglutamate Aβ cascade as drug target in Alzheimer’s disease

Methylome-wide association study of antidepressant use in Generation Scotland and the Netherlands Twin Register implicates the innate immune system

Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of the UK Biobank

NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance

Dopamine and fear memory formation in the human amygdala

Epigenome-wide association study of alcohol consumption in N = 8161 individuals and relevance to alcohol use disorder pathophysiology: identification of the cystine/glutamate transporter SLC7A11 as a top target

Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes

Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatients

Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine

A neuropsychosocial signature predicts longitudinal symptom changes in women with irritable bowel syndrome

Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale

Child abuse associates with increased recruitment of perineuronal nets in the ventromedial prefrontal cortex: a possible implication of oligodendrocyte progenitor cells

Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches

Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants

The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders

Clinical correlation but no elevation of striatal dopamine synthesis capacity in two independent cohorts of medication-free individuals with schizophrenia

Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids

Dopamine D2 receptors modulate the cholinergic pause and inhibitory learning

Correction: Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts

Cell-type- and region-specific modulation of cocaine seeking by micro-RNA-1 in striatal projection neurons

Persistent and distressing psychotic-like experiences using adolescent brain cognitive development℠ study data

Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer’s disease

Genome-wide interaction study with major depression identifies novel variants associated with cognitive function

Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis

Strong and weak cross-inheritance of substance use disorders in a nationally representative sample